What is BioSked?
BioSked operates at the intersection of artificial intelligence and clinical operations, providing the Momentum platform to hospitals, clinics, and specialized medical practices. By automating complex physician scheduling, tracking relative value units (RVUs), and ensuring regulatory compliance, the company addresses critical administrative bottlenecks that often plague large-scale healthcare providers. With a footprint spanning 1,000 sites across 9 countries and a user base exceeding 50,000 daily professionals, BioSked has established itself as a vital infrastructure layer for modern medical facilities, effectively reducing burnout and optimizing patient access through data-driven resource allocation.
How much funding has BioSked raised?
BioSked has raised a total of $123K across 1 funding round:
Stock/Share Issuance
$123K
Stock/Share Issuance (2025): $123K, investors not publicly disclosed
Key Investors in BioSked
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for BioSked?
With this late-stage financing, BioSked is positioned to accelerate its international expansion and deepen the integration of its AI capabilities within existing hospital information systems. The strategic focus will likely shift toward enhancing predictive analytics for staffing requirements, thereby allowing healthcare organizations to anticipate demand surges with greater precision. As the company matures, the emphasis will remain on maintaining its competitive edge in the health-tech sector by refining its scheduling algorithms and expanding its footprint in high-acuity environments such as emergency medicine and radiology, where operational efficiency is paramount to patient outcomes.
See full BioSked company page
